Skip to main content

Smith J. Jefferson's Form 4 filing

Precision Biosciences Inc (DTIL) · filed Jan 22, 2026

Accession no.
0001628280-26-003146
Filed
Jan 22, 2026
Trade date
Jan 20-21, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $41.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Smith J. JeffersonCIK 0001770169Officer (Chief Research Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 20, 2026Common StockMOption exerciseAcquired+2,500––93,718Direct
Jan 20, 2026Common StockMOption exerciseAcquired+10,447––104,165Direct
Jan 21, 2026Common StockMOption exerciseAcquired+16,219––120,384Direct
Jan 21, 2026Common StockSSaleDisposed−10,200$4.03−$41,106110,184Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 20, 2026Common StockMOption exerciseDisposed−2,500$0.00$00Direct
Jan 20, 2026Common StockMOption exerciseDisposed−10,447$0.00$010,447Direct
Jan 20, 2026Common StockMOption exerciseDisposed−16,219$0.00$016,219Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)